Blair William & Co. IL Decreases Stock Holdings in Align Technology, Inc. $ALGN

Blair William & Co. IL trimmed its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 52.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,979 shares of the medical equipment provider’s stock after selling 38,628 shares during the quarter. Blair William & Co. IL’s holdings in Align Technology were worth $6,623,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. CX Institutional purchased a new stake in Align Technology in the first quarter worth $136,000. Wealth Enhancement Advisory Services LLC increased its position in Align Technology by 44.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,380 shares of the medical equipment provider’s stock worth $1,490,000 after buying an additional 2,881 shares during the last quarter. Factory Mutual Insurance Co. increased its position in Align Technology by 20.5% in the first quarter. Factory Mutual Insurance Co. now owns 202,793 shares of the medical equipment provider’s stock worth $32,216,000 after buying an additional 34,500 shares during the last quarter. Exchange Traded Concepts LLC increased its position in Align Technology by 27.7% in the first quarter. Exchange Traded Concepts LLC now owns 4,929 shares of the medical equipment provider’s stock worth $783,000 after buying an additional 1,068 shares during the last quarter. Finally, M.E. Allison & CO. Inc. purchased a new stake in Align Technology in the first quarter worth $233,000. 88.43% of the stock is owned by hedge funds and other institutional investors.

Align Technology Stock Performance

NASDAQ:ALGN opened at $125.79 on Monday. The firm has a market capitalization of $9.12 billion, a price-to-earnings ratio of 21.21, a P/E/G ratio of 1.43 and a beta of 1.70. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $246.19. The stock has a fifty day moving average of $135.61 and a 200 day moving average of $164.38.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.57 by ($0.08). The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. Align Technology’s quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the prior year, the business posted $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. Equities analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has initiated a stock buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

Insider Transactions at Align Technology

In other Align Technology news, CEO Joseph M. Hogan acquired 7,576 shares of the company’s stock in a transaction that occurred on Friday, August 1st. The stock was bought at an average price of $131.49 per share, with a total value of $996,168.24. Following the completion of the purchase, the chief executive officer owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.66% of the company’s stock.

Analyst Ratings Changes

ALGN has been the subject of a number of recent research reports. Wells Fargo & Company decreased their target price on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. Stifel Nicolaus decreased their target price on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research report on Thursday, July 31st. Zacks Research raised Align Technology from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 30th. Jefferies Financial Group reiterated a “hold” rating and issued a $140.00 price target (down from $215.00) on shares of Align Technology in a research report on Friday. Finally, Mizuho set a $210.00 price target on Align Technology in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $200.00.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.